|
IPHAF
|
Isotechnika Reports Pact With FDA On SPA For Phase 3 Trial Of Voclosporin...
|
|
IPHAF
|
EDMONTON, Alberta, Mar 12, 2012 (GlobeNewswire via COMTEX) -- Isotechnika...
|
|
IPHAF
|
I am not sure anyone is much of a fancy investor around here. The trouble...
|
|
IPHAF
|
The psychotropic's posts do provide some comic relief and I do log out on...
|
|
IPHAF
|
Georgealphabeta - I'm not sure we can conclude anything specific from...
|
|
IPHAF
|
Freeda, a pollyanna is blindly optimistic - irrationally so. A Casandra is a...
|
|
IPHAF
|
As I reviewed in a previous post on uveitis - an indication that continues in...
|
|
IPHAF
|
An incoherent and dated October 2010 allvoices.com "story" full of...
|
|
IPHAF
|
As far as i am aware - pending the initiation of a Phase 3 Clinical trial...
|
|
IPHAF
|
There is not much news available on uveitus other than the fact that the...
|
|
IPHAF
|
While the market for transplant indications for calcineurin inhibitor drugs...
|
|
IPHAF
|
I mentioned in a previous post that voclosporin's advantage over the...
|
|
IPHAF
|
If voclosporin clears the Phase 3 trial hurdles in the US and Europe - two...
|
|
IPHAF
|
You are right - it is all speculation. But it's indeed true that tiny ISA...
|
|
IPHAF
|
I agree with you entirely Antoninus that a board shuffle is a meaningless...
|
|
IPHAF
|
If I am reading the reports rightly, ISA's voclosporin's potential as...
|
|
IPHAF
|
The day ended even. Volume was however in the quarter million share range...
|
|
IPHAF
|
ISA is trading well this morning at 16 cents and 146,000 shares. It's not...
|
|
IPHAF
|
Currently trading at 17 cents - have a great day
|
|
IPHAF
|
EDMONTON, Alberta, Jan. 6, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc...
|